Opinion on the Optimal Histologic Evaluation of the Bone Marrow in Nonclinical Toxicity Studies.

Kathleen E Biddle

Toxicologic pathology 2022 Feb

filter terms:

Identification of bone marrow toxicity is an important issue in drug development and toxicologic pathologists play a critical role in that identification. Knowledge of the general components of bone marrow, relevant anatomical and species differences, and the standard approach (routine systematic histological evaluation of the bone marrow in conjunction with analysis of the peripheral complete blood count data) will be reviewed. Specific morphologic features that anatomic pathologists should look for in the various components of bone marrow as well as suggested terminology for bone marrow findings will be discussed. Finally, an opinion on the limitations of the standard approach to bone marrow evaluation will be provided including general recommendations on when additional methods (image analysis of hematoxylin and eosin stained slides, flow cytometry or Sysmex XT 2000iV analysis, cytological evaluation of bone marrow smears, in vitro models, and transmission electron microscopy) might be useful in the detection or further characterization of bone marrow toxicity. [Box: see text].

Citation

Kathleen E Biddle. Opinion on the Optimal Histologic Evaluation of the Bone Marrow in Nonclinical Toxicity Studies. Toxicologic pathology. 2022 Feb;50(2):266-273